Curasight Feed

Land	Danmark
Lista	Spotlight DK
Sektor	Hälsovård
Industri	Medicinteknik

2024-04-16 20:39:38 Curasight announces approval of clinical trial application (CTA) for phase 2 trial with uTRACE[®] in prostate cancer patients -1,93% | 0,10 MDKK

2024-04-12 11:58:04 Curasight announces change in the Board of Directors +3,09% | 0,07 MDKK

2024-03-21 12:30:31 Resolutions of the Annual General Meeting 2024 of Curasight A/S -6,03% | 0,13 MDKK

2024-03-11 21:53:10 Curasight not to proceed with rights issue; evaluating alternative financing opportunities -28,28%

2024-03-06 11:26:47 Curasight: Notice of Annual General Meeting 2024 +2,36%

2024-02-23 08:35:35 The subscription period in Curasight's rights issue begins today -1,23% | 0,59 MDKK

2024-02-22 12:47:45 Curasight publishes information memorandum in connection with forthcoming rights issue +1,25% | 0,17 MDKK

2024-02-22 08:46:13 Curasight: Annual Report for the fiscal year 2023 +1,25% | 0,17 MDKK

2024-02-22 07:00:00 Curasight: Year-end report October - December 2023 +1,25% | 0,17 MDKK

2024-02-13 08:13:40 Curasight resolves on a rights issue of up to DKK 51.2 million to accelerate its therapeutic strategy -8,33% | 0,39 MDKK

2024-02-13 08:11:14 Curasight announces acceleration of therapeutic strategy to strengthen position as a radiopharmaceutical theranostic company -8,33% | 0,39 MDKK

2024-01-22 07:00:00 Curasight A/S Achieves First Milestone under collaboration with Curium Inc. +0,80% | 0,20 MDKK

2023-12-18 18:31:25 Curasight A/S submits clinical trial application (CTA) for phase 2 trial with uTRACE[®] in prostate cancer patients -2,86% | 0,36 MDKK

2023-12-13 17:53:30 Curasight A/S appoints CRO to run Phase 2 study with uTRACE[®] in prostate cancer +4,89% | 0,21 MDKK

2023-11-24 07:00:00 Curasight to present at HC Andersen Capital and Stokk.io -2,45% | 0,04 MDKK

2023-11-23 07:00:00 Curasight: Interim Report January - September 2023 +2,22% | 0,04 MDKK

2023-10-18 07:20:00 Curasight A/S reports positive preclinical results with uTREAT[®] in lung cancer (NSCLC) -1,10% | 0,14 MDKK

2023-09-14 17:20:00 Curasight: Positive results from the Phase II study of uTRACE in brain cancer presented at the World Molecular Imaging Congress (WMIC) 2023 in Prague -2,02% | 0,06 MDKK

2023-08-25 12:26:39 Curasight to present at HC Andersen Capital and at HC Andersen Life Science seminar -1,07% | 0,24 MDKK

2023-08-24 07:22:18 Curasight: Interim Report January - June 2023 -1,06% | 0,08 MDKK

2023-06-29 08:53:01 Curasight: Positive results in uPAR-PET/MR Phase II study in brain cancer 0,00% | 0,63 MDKK

2023-06-07 08:28:03 Curasight A/S reports positive preclinical results with uTREAT[®] in aggressive brain cancer (glioblastoma) 0,00% | 0,67 MDKK

2023-05-26 14:58:54 Curasight to present at HC Andersen Capital and Økonomisk Ugebrev -0,81% | 0,27 MDKK

2023-05-25 07:00:00 Curasight: Interim report Q1 2023 -1,20% | 0,47 MDKK

2023-05-01 17:20:00 Curasight and Curium announce global partnership for uTRACE[®] in prostate cancer 0,00% | 0,05 MDKK

2023-03-30 12:55:45 Resolutions of the Annual General Meeting of Curasight A/S -2,82% | 0,08 MDKK

2023-03-15 15:52:50 Curasight: Notice of Annual General Meeting 2023 -8,38% | 0,15 MDKK

2023-02-23 08:00:00 Curasight: Annual Report for the fiscal year 2022 -1,73% | 0,16 MDKK

2023-02-23 07:00:00 Curasight: Year-end report October - December 2022 -1,73% | 0,16 MDKK

2023-02-22 10:38:33 Curasight to present at HC Andersen Capital -2,15% | 0,14 MDKK

2023-01-16 11:03:50 Curasight to present at Redeye Fight Cancer Seminar +5,50% | 0,08 MDKK

2022-11-24 07:00:00 Curasight: Interim Report January - September 2022 0,00% | 0,02 MDKK

2022-11-23 09:57:18 Curasight to present at HC Andersen Capital -3,61% | 0,13 MDKK

2022-11-17 08:36:49 Curasight to present at SEB Healthcare Seminar 2022 +10,12% | 0,04 MDKK

2022-10-13 17:22:00 Curasight initiates pre-clinical studies with uTREAT[®] therapy in head and neck cancer (HNSCC) and neuroendocrine tumors (NET) +1,20% | 0,04 MDKK

2022-09-04 22:40:50 Transaction with shares in Curasight A/S made by managerial employee -5,10% | 0,05 MDKK

2022-08-25 13:43:31 Curasight to present at HC Andersen Capital -2,37% | 0,05 MDKK

2022-08-25 07:00:00 Curasight: Interim Report January - June 2022 -2,37% | 0,05 MDKK

2022-06-30 08:40:53 Curasight: Recruitment completed in uPAR-PET study in brain cancer -0,56% | 0,05 MDKK

2022-06-24 18:15:51 Transaction with shares in Curasight A/S made by managerial employee +0,77% | 0,03 MDKK

2022-06-07 17:22:00 Curasight issues warrants for launch of long-term incentive program -0,43% | 0,09 MDKK

2022-05-24 07:00:00 Curasight: Interim Report January - March 2022 0,00% | 0,19 MDKK

2022-05-16 08:09:32 Curasight to present at Kapital Partners Life Science seminar +24,41% | 0,10 MDKK

2022-04-27 14:46:37 Resolutions of the Annual General Meeting of Curasight A/S -4,24% | 0,21 MDKK

2022-04-22 07:00:00 Curasight: Additional US patent application relating to uTRACE[®] is accepted for grant -0,12% | 0,05 MDKK

2022-04-12 08:00:00 Curasight: Notice of Annual General Meeting 2022 -4,07% | 0,10 MDKK

2022-03-09 08:40:08 Curasight announces new date of the Annual General Meeting and an updated financial calendar 2022 +1,10% | 0,25 MDKK

2022-02-24 08:30:00 Curasight: Annual Report for the fiscal year 2021 -1,90% | 1,18 MDKK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

2024-11-21	Kvartalsrapport 2024-Q3
2024-08-22	Kvartalsrapport 2024-Q2
2024-05-23	Kvartalsrapport 2024-Q1
2024-03-22	Ordinarie utdelning CURAS 0.00 DKK
2024-03-21	Årsstämma 2024
2024-02-22	Bokslutskommuniké 2023
2023-11-23	Kvartalsrapport 2023-Q3
2023-08-24	Kvartalsrapport 2023-Q2
2023-05-25	Kvartalsrapport 2023-Q1
2023-03-31	Ordinarie utdelning CURAS 0.00 DKK
2023-03-30	Årsstämma 2023
2023-02-23	Bokslutskommuniké 2022
2022-11-24	Kvartalsrapport 2022-Q3
2022-08-25	Kvartalsrapport 2022-Q2
2022-05-24	Kvartalsrapport 2022-Q1
2022-04-27	Årsstämma 2022
2022-03-25	Ordinarie utdelning CURAS 0.00 DKK
2022-02-24	Bokslutskommuniké 2021
2021-11-25	Kvartalsrapport 2021-Q3
2021-08-24	Kvartalsrapport 2021-Q2
2021-06-01	Extra Bolagsstämma 2021
2021-05-20	Kvartalsrapport 2021-Q1
2021-03-26	Ordinarie utdelning CURAS 0.00 DKK
2021-03-25	Årsstämma 2021
2021-02-24	Bokslutskommuniké 2020
2020-11-30	Kvartalsrapport 2020-Q3

Curasight

Kalender

Beskrivning

Curasight

Kalender

Beskrivning

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden